BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Van Bulck M, Sierra-Magro A, Alarcon-Gil J, Perez-Castillo A, Morales-Garcia JA. Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease. Int J Mol Sci 2019;20:E719. [PMID: 30743990 DOI: 10.3390/ijms20030719] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 27.0] [Reference Citation Analysis]
Number Citing Articles
1 Alov P, Stoimenov H, Lessigiarska I, Pencheva T, Tzvetkov NT, Pajeva I, Tsakovska I. In Silico Identification of Multi-Target Ligands as Promising Hit Compounds for Neurodegenerative Diseases Drug Development. IJMS 2022;23:13650. [DOI: 10.3390/ijms232113650] [Reference Citation Analysis]
2 Bacchella C, Dell'acqua S, Nicolis S, Monzani E, Casella L. The reactivity of copper complexes with neuronal peptides promoted by catecholamines and its impact on neurodegeneration. Coordination Chemistry Reviews 2022;471:214756. [DOI: 10.1016/j.ccr.2022.214756] [Reference Citation Analysis]
3 Reich N, Hölscher C. The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review. Front Neurosci 2022;16:970925. [DOI: 10.3389/fnins.2022.970925] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Fang Y, Wang J, Zhao M, Zheng Q, Ren C, Wang Y, Zhang J. Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy. J Med Chem 2022. [PMID: 36006861 DOI: 10.1021/acs.jmedchem.2c00844] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Alarcon-Gil J, Sierra-Magro A, Morales-Garcia JA, Sanz-SanCristobal M, Alonso-Gil S, Cortes-Canteli M, Niso-Santano M, Martínez-Chacón G, Fuentes JM, Santos A, Perez-Castillo A. Neuroprotective and Anti-Inflammatory Effects of Linoleic Acid in Models of Parkinson's Disease: The Implication of Lipid Droplets and Lipophagy. Cells 2022;11:2297. [PMID: 35892594 DOI: 10.3390/cells11152297] [Reference Citation Analysis]
6 Espinosa JM, Castellano JM, Garcia-rodriguez S, Quintero-flórez A, Carrasquilla N, Perona JS. Lipophilic Bioactive Compounds Transported in Triglyceride-Rich Lipoproteins Modulate Microglial Inflammatory Response. IJMS 2022;23:7706. [DOI: 10.3390/ijms23147706] [Reference Citation Analysis]
7 Kemadjou Dibacto RE, Akamba Ambamba BD, Ella FA, Biyegue Nyangono CF, Kamga Nanhah JV, Fonkoua M, Minka RS, Ngondi JL. The neuroprotective effect of Xylopia parviflora against aluminum chloride-induced neurotoxicity in rats. Heliyon 2022;8:e09896. [PMID: 35855984 DOI: 10.1016/j.heliyon.2022.e09896] [Reference Citation Analysis]
8 Wdowiak K, Walkowiak J, Pietrzak R, Bazan-woźniak A, Cielecka-piontek J. Bioavailability of Hesperidin and Its Aglycone Hesperetin—Compounds Found in Citrus Fruits as a Parameter Conditioning the Pro-Health Potential (Neuroprotective and Antidiabetic Activity)—Mini-Review. Nutrients 2022;14:2647. [DOI: 10.3390/nu14132647] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Sola P, Krishnamurthy PT, Kumari M, Byran G, Gangadharappa HV, Garikapati KK. Neuroprotective approaches to halt Parkinson's disease progression. Neurochem Int 2022;158:105380. [PMID: 35718278 DOI: 10.1016/j.neuint.2022.105380] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Budak M, Bayraktaroglu Z, Hanoglu L. The effects of repetitive transcranial magnetic stimulation and aerobic exercise on cognition, balance and functional brain networks in patients with Alzheimer's disease. Cogn Neurodyn. [DOI: 10.1007/s11571-022-09818-x] [Reference Citation Analysis]
11 Stojkovic D, Drakulic D, Dias MI, Zengin G, Barros L, Ivanov M, Gašic U, Rajcevic N, Stevanovic M, Ferreira ICFR, Sokovic M. Phlomis fruticosa L. exerts in vitro antineurodegenerative and antioxidant activities and induces prooxidant effect in glioblastoma cell line. EXCLI J 2022;21:387-99. [PMID: 35368464 DOI: 10.17179/excli2021-4487] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Amirifar L, Shamloo A, Nasiri R, de Barros NR, Wang ZZ, Unluturk BD, Libanori A, Ievglevskyi O, Diltemiz SE, Sances S, Balasingham I, Seidlits SK, Ashammakhi N. Brain-on-a-chip: Recent advances in design and techniques for microfluidic models of the brain in health and disease. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121531] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
13 Tabatabaei Malazy O, Bandarian F, Qorbani M, Mohseni S, Mirsadeghi S, Peimani M, Larijani B. The effect of metformin on cognitive function: A systematic review and meta-analysis. J Psychopharmacol 2022;:2698811211057304. [PMID: 35297284 DOI: 10.1177/02698811211057304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Li L, Zhang B, De Pieri L, Wu Y, Birch K, Boesch C, Wan C. Nobiletin Protects Endothelial Cell Function via Upregulation of eNOS/ET-1 and Antioxidant Status-Related Genes under Nonstimulated and Inflammatory Conditions. Journal of Food Quality 2022;2022:1-8. [DOI: 10.1155/2022/9119547] [Reference Citation Analysis]
15 Brookes A, Ji L, Bradshaw TD, Stocks M, Gray D, Butler J, Gershkovich P. Is Oral Lipid-Based Delivery for Drug Targeting to the Brain Feasible? Eur J Pharm Biopharm 2022:S0939-6411(22)00025-X. [PMID: 35149190 DOI: 10.1016/j.ejpb.2022.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Maccioni RB, Calfío C, González A, Lüttges V. Novel Nutraceutical Compounds in Alzheimer Prevention. Biomolecules 2022;12:249. [DOI: 10.3390/biom12020249] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
17 Oláh J, Szénási T, Lehotzky A, Norris V, Ovádi J. Challenges in Discovering Drugs That Target the Protein-Protein Interactions of Disordered Proteins. Int J Mol Sci 2022;23:1550. [PMID: 35163473 DOI: 10.3390/ijms23031550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Peze-Heidsieck E, Bonnifet T, Znaidi R, Ravel-Godreuil C, Massiani-Beaudoin O, Joshi RL, Fuchs J. Retrotransposons as a Source of DNA Damage in Neurodegeneration. Front Aging Neurosci 2021;13:786897. [PMID: 35058771 DOI: 10.3389/fnagi.2021.786897] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
19 Cortes-canteli M, Perez-castillo A. Alzheimer׳s Disease: One of the Pandemics of the 21st Century. Reference Module in Life Sciences 2022. [DOI: 10.1016/b978-0-12-821618-7.00247-9] [Reference Citation Analysis]
20 Loureiro JC, de Almeida Lima e Silva LF, Pais MV, Forlenza OV. New Perspectives for Treatment in Alzheimer’s Disease. Pharmacological Treatment of Alzheimer's Disease 2022. [DOI: 10.1007/978-3-030-94383-7_10] [Reference Citation Analysis]
21 Du Y, Zhao W, Du L, Liu J. Neuropsychiatric symptoms associated with the COVID-19 and its potential nervous system infection mechanism: the role of imaging in the study. Psychoradiology 2021;1:199-211. [DOI: 10.1093/psyrad/kkab019] [Reference Citation Analysis]
22 Voronin MV, Kadnikov IA, Zainullina LF, Logvinov IO, Verbovaya ER, Antipova TA, Vakhitova YV, Seredenin SB. Neuroprotective Properties of Quinone Reductase 2 Inhibitor M-11, a 2-Mercaptobenzimidazole Derivative. Int J Mol Sci 2021;22:13061. [PMID: 34884863 DOI: 10.3390/ijms222313061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Saeger HN, Olson DE. Psychedelic-inspired approaches for treating neurodegenerative disorders. J Neurochem 2021. [PMID: 34816433 DOI: 10.1111/jnc.15544] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Sharma S. Alzheimer’s disease: Causes, treatment & basic science review. IJCAAP 2021;6:108-116. [DOI: 10.18231/j.ijcaap.2021.020] [Reference Citation Analysis]
25 Silva-Pilipich N, Smerdou C, Vanrell L. A Small Virus to Deliver Small Antibodies: New Targeted Therapies Based on AAV Delivery of Nanobodies. Microorganisms 2021;9:1956. [PMID: 34576851 DOI: 10.3390/microorganisms9091956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Cross DJ, Huber BR, Silverman MA, Cline MM, Gill TB, Cross CG, Cook DG, Minoshima S. Intranasal Paclitaxel Alters Alzheimer's Disease Phenotypic Features in 3xTg-AD Mice. J Alzheimers Dis 2021;83:379-94. [PMID: 34308901 DOI: 10.3233/JAD-210109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
27 Beutgen VM, Schmelter C, Pfeiffer N, Grus FH. Contribution of the Commensal Microflora to the Immunological Homeostasis and the Importance of Immune-Related Drug Development for Clinical Applications. Int J Mol Sci 2021;22:8896. [PMID: 34445599 DOI: 10.3390/ijms22168896] [Reference Citation Analysis]
28 Akanji MA, Rotimi DE, Elebiyo TC, Awakan OJ, Adeyemi OS. Redox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders. Oxid Med Cell Longev 2021;2021:9971885. [PMID: 34394839 DOI: 10.1155/2021/9971885] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
29 Drabik K, Piecyk K, Wolny A, Szulc-Dąbrowska L, Dębska-Vielhaber G, Vielhaber S, Duszyński J, Malińska D, Szczepanowska J. Adaptation of mitochondrial network dynamics and velocity of mitochondrial movement to chronic stress present in fibroblasts derived from patients with sporadic form of Alzheimer's disease. FASEB J 2021;35:e21586. [PMID: 33960016 DOI: 10.1096/fj.202001978RR] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Devault KR, Achem SR. Esophageal Disease in Older Patients. The Esophagus 2021. [DOI: 10.1002/9781119599692.ch47] [Reference Citation Analysis]
31 Golovinskaia O, Wang CK. Review of Functional and Pharmacological Activities of Berries. Molecules 2021;26:3904. [PMID: 34202412 DOI: 10.3390/molecules26133904] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 20.0] [Reference Citation Analysis]
32 Sharma VK, Mehta V, Singh TG. Alzheimer's Disorder: Epigenetic Connection and Associated Risk Factors. Curr Neuropharmacol 2020;18:740-53. [PMID: 31989902 DOI: 10.2174/1570159X18666200128125641] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 22.0] [Reference Citation Analysis]
33 Cruz-Vicente P, Passarinha LA, Silvestre S, Gallardo E. Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches. Molecules 2021;26:2193. [PMID: 33920326 DOI: 10.3390/molecules26082193] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
34 Mathew B, Oh JM, Baty RS, Batiha GE, Parambi DGT, Gambacorta N, Nicolotti O, Kim H. Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders. Environ Sci Pollut Res Int 2021;28:38855-66. [PMID: 33743158 DOI: 10.1007/s11356-021-13320-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
35 Ma L, Gholam Azad M, Dharmasivam M, Richardson V, Quinn RJ, Feng Y, Pountney DL, Tonissen KF, Mellick GD, Yanatori I, Richardson DR. Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies. Redox Biol 2021;41:101896. [PMID: 33799121 DOI: 10.1016/j.redox.2021.101896] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 27.0] [Reference Citation Analysis]
36 Li G, Luo W, Wang B, Qian C, Ye Y, Li Y, Zhang S. HMGA1 Induction of miR-103/107 Forms a Negative Feedback Loop to Regulate Autophagy in MPTP Model of Parkinson's Disease. Front Cell Neurosci 2020;14:620020. [PMID: 33536877 DOI: 10.3389/fncel.2020.620020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
37 Yue T, Sheng Q, Luo Y, Xiao Z, Wang Y, Song W, Yan M, Niu H, Zhang T, Li N. Biflavonoids and Oligomeric Flavonoids from Food. Handbook of Dietary Phytochemicals 2021. [DOI: 10.1007/978-981-15-4148-3_7] [Reference Citation Analysis]
38 Pathak S, Kale A, Kumar CMS, Sheikh M. Role of Cytoskeletal Protein, Actin in Various Diseases. Dietary Phytochemicals 2021. [DOI: 10.1007/978-3-030-72999-8_6] [Reference Citation Analysis]
39 Torfeh A, Abdolmaleki Z, Nazarian S, Shirazi Beheshtiha SH. Modafinil-coated nanoparticle increases expressions of brain-derived neurotrophic factor, glial cell line-derived neurotrophic factor and neuronal nuclear protein, and protects against middle cerebral artery occlusion-induced neuron apoptosis in the rat hippocampus. Anat Rec (Hoboken) 2021;304:2032-43. [PMID: 33345406 DOI: 10.1002/ar.24581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Wang JKT. Uniting homeostatic plasticity and exosome biology: A revision of the conceptual framework for drug discovery in neurodegenerative diseases? Adv Pharmacol 2021;90:277-306. [PMID: 33706937 DOI: 10.1016/bs.apha.2020.10.002] [Reference Citation Analysis]
41 Więckowska A, Szałaj N, Góral I, Bucki A, Latacz G, Kiec-Kononowicz K, Bautista-Aguilera ÒM, Romero A, Ramos E, Egea J, Farré Alíns V, González-Rodríguez Á, López-Muñoz F, Chioua M, Marco-Contelles J. In Vitro and In Silico ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases. ACS Chem Neurosci 2020;11:3793-801. [PMID: 33143412 DOI: 10.1021/acschemneuro.0c00489] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
42 Del Prete E, Beatino MF, Campese N, Giampietri L, Siciliano G, Ceravolo R, Baldacci F. Fluid Candidate Biomarkers for Alzheimer's Disease: A Precision Medicine Approach. J Pers Med 2020;10:E221. [PMID: 33187336 DOI: 10.3390/jpm10040221] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
43 Morales-Garcia JA, Calleja-Conde J, Lopez-Moreno JA, Alonso-Gil S, Sanz-SanCristobal M, Riba J, Perez-Castillo A. N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo. Transl Psychiatry 2020;10:331. [PMID: 32989216 DOI: 10.1038/s41398-020-01011-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 14.5] [Reference Citation Analysis]
44 Ruz C, Alcantud JL, Vives Montero F, Duran R, Bandres-Ciga S. Proteotoxicity and Neurodegenerative Diseases. Int J Mol Sci 2020;21:E5646. [PMID: 32781742 DOI: 10.3390/ijms21165646] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
45 Zheng H, Shi C, Luo H, Fan L, Yang Z, Hu X, Zhang Z, Zhang S, Hu Z, Fan Y, Yang J, Mao C, Xu Y. α-Synuclein in Parkinson's Disease: Does a Prion-Like Mechanism of Propagation from Periphery to the Brain Play a Role? Neuroscientist 2021;27:367-87. [PMID: 32729773 DOI: 10.1177/1073858420943180] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
46 Ghali MGZ, Marchenko V, Yaşargil MG, Ghali GZ. Structure and function of the perivascular fluid compartment and vertebral venous plexus: Illumining a novel theory on mechanisms underlying the pathogenesis of Alzheimer's, cerebral small vessel, and neurodegenerative diseases. Neurobiol Dis 2020;144:105022. [PMID: 32687942 DOI: 10.1016/j.nbd.2020.105022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
47 Patwa J, Flora SJS. Heavy Metal-Induced Cerebral Small Vessel Disease: Insights into Molecular Mechanisms and Possible Reversal Strategies. Int J Mol Sci 2020;21:E3862. [PMID: 32485831 DOI: 10.3390/ijms21113862] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
48 Rai SN, Singh C, Singh A, Singh MP, Singh BK. Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer’s Disease. Mol Neurobiol 2020;57:3075-88. [DOI: 10.1007/s12035-020-01945-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 11.5] [Reference Citation Analysis]
49 Vinklarova L, Schmidt M, Benek O, Kuca K, Gunn-Moore F, Musilek K. Friend or enemy? Review of 17β-HSD10 and its role in human health or disease. J Neurochem 2020;155:231-49. [PMID: 32306391 DOI: 10.1111/jnc.15027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
50 Panaro MA, Benameur T, Porro C. Hypothalamic Neuropeptide Brain Protection: Focus on Oxytocin. J Clin Med 2020;9:E1534. [PMID: 32438751 DOI: 10.3390/jcm9051534] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
51 Ahmed GA, El Hotaby W, Abbas L, Sherif HHA, Kamel G, Khalil SKH. Synchrotron Fourier transform infrared microspectroscopy (sFTIRM) analysis of Al-induced Alzheimer's disease in rat brain cortical tissue. Spectrochim Acta A Mol Biomol Spectrosc 2020;239:118421. [PMID: 32473558 DOI: 10.1016/j.saa.2020.118421] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
52 Ahmad SS, Sinha M, Ahmad K, Khalid M, Choi I. Study of Caspase 8 Inhibition for the Management of Alzheimer's Disease: A Molecular Docking and Dynamics Simulation. Molecules 2020;25:E2071. [PMID: 32365525 DOI: 10.3390/molecules25092071] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
53 Arbo BD, André-Miral C, Nasre-Nasser RG, Schimith LE, Santos MG, Costa-Silva D, Muccillo-Baisch AL, Hort MA. Resveratrol Derivatives as Potential Treatments for Alzheimer's and Parkinson's Disease. Front Aging Neurosci 2020;12:103. [PMID: 32362821 DOI: 10.3389/fnagi.2020.00103] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 21.0] [Reference Citation Analysis]
54 Chariou PL, Ortega-Rivera OA, Steinmetz NF. Nanocarriers for the Delivery of Medical, Veterinary, and Agricultural Active Ingredients. ACS Nano 2020;14:2678-701. [PMID: 32125825 DOI: 10.1021/acsnano.0c00173] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 36.5] [Reference Citation Analysis]
55 Yang C, Zhang T, Wang W, Xiang Y, Huang Q, Xie C, Zhao L, Zheng H, Yang Y, Gao H. Brain-Region Specific Metabolic Abnormalities in Parkinson's Disease and Levodopa-Induced Dyskinesia. Front Aging Neurosci 2020;12:75. [PMID: 32256342 DOI: 10.3389/fnagi.2020.00075] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
56 Anwar S, Rivest S. Alzheimer's disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation. Expert Opin Ther Targets 2020;24:331-44. [PMID: 32129117 DOI: 10.1080/14728222.2020.1738391] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
57 Cordaro M, Cuzzocrea S, Crupi R. An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events. Antioxidants (Basel) 2020;9:E216. [PMID: 32150935 DOI: 10.3390/antiox9030216] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 14.5] [Reference Citation Analysis]
58 Alonso-garrido M, Tedeschi P, Maietti A, Font G, Marchetti N, Manyes L. Mitochondrial transcriptional study of the effect of aflatoxins, enniatins and carotenoids in vitro in a blood brain barrier model. Food and Chemical Toxicology 2020;137:111077. [DOI: 10.1016/j.fct.2019.111077] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
59 Baldacci F, Mazzucchi S, Della Vecchia A, Giampietri L, Giannini N, Koronyo-Hamaoui M, Ceravolo R, Siciliano G, Bonuccelli U, Elahi FM, Vergallo A, Lista S, Giorgi FS, Hampel H. The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases. Expert Rev Mol Diagn 2020;20:421-41. [PMID: 32066283 DOI: 10.1080/14737159.2020.1731306] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
60 Silva RFM, Pogačnik L. Polyphenols from Food and Natural Products: Neuroprotection and Safety. Antioxidants (Basel) 2020;9:E61. [PMID: 31936711 DOI: 10.3390/antiox9010061] [Cited by in Crossref: 103] [Cited by in F6Publishing: 106] [Article Influence: 51.5] [Reference Citation Analysis]
61 Yue T, Sheng Q, Luo Y, Xiao Z, Wang Y, Song W, Yan M, Niu H, Zhang T, Li N. Biflavonoids and Oligomeric Flavonoids from Food. Handbook of Dietary Phytochemicals 2020. [DOI: 10.1007/978-981-13-1745-3_7-1] [Reference Citation Analysis]
62 Cieślik M, Czapski GA, Wójtowicz S, Wieczorek I, Wencel PL, Strosznajder RP, Jaber V, Lukiw WJ, Strosznajder JB. Alterations of Transcription of Genes Coding Anti-oxidative and Mitochondria-Related Proteins in Amyloid β Toxicity: Relevance to Alzheimer's Disease. Mol Neurobiol 2020;57:1374-88. [PMID: 31734880 DOI: 10.1007/s12035-019-01819-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
63 Castellano JM, Garcia-Rodriguez S, Espinosa JM, Millan-Linares MC, Rada M, Perona JS. Oleanolic Acid Exerts a Neuroprotective Effect Against Microglial Cell Activation by Modulating Cytokine Release and Antioxidant Defense Systems. Biomolecules. 2019;9. [PMID: 31683841 DOI: 10.3390/biom9110683] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
64 Kumar PS, Kumar KB, Obadiah A, Kumar SJ, Mohanapriya R, Durairaj A, Ramanathan S, Vasanthkumar S. Synthesis, Molecular Docking, Cytotoxicity and Antioxidant Activity Evaluation of Isoindoline-1,3-dione Derivatives. Asian J Chem 2019;31:2548-2556. [DOI: 10.14233/ajchem.2019.22185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Zeng J, Martin A, Han X, Shirihai OS, Grinstaff MW. Biodegradable PLGA Nanoparticles Restore Lysosomal Acidity and Protect Neural PC-12 Cells against Mitochondrial Toxicity. Ind Eng Chem Res 2019;58:13910-7. [DOI: 10.1021/acs.iecr.9b02003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
66 Nakajima A, Ohizumi Y. Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease. Int J Mol Sci 2019;20:E3380. [PMID: 31295812 DOI: 10.3390/ijms20143380] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 23.3] [Reference Citation Analysis]
67 Ma J, Gao J, Wang J, Xie A. Prion-Like Mechanisms in Parkinson's Disease. Front Neurosci 2019;13:552. [PMID: 31275093 DOI: 10.3389/fnins.2019.00552] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 21.3] [Reference Citation Analysis]
68 Hussain G, Huang J, Rasul A, Anwar H, Imran A, Maqbool J, Razzaq A, Aziz N, Makhdoom EUH, Konuk M, Sun T. Putative Roles of Plant-Derived Tannins in Neurodegenerative and Neuropsychiatry Disorders: An Updated Review. Molecules 2019;24:E2213. [PMID: 31200495 DOI: 10.3390/molecules24122213] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 9.7] [Reference Citation Analysis]
69 Baldacci F, Lista S, Vergallo A, Palermo G, Giorgi FS, Hampel H. A frontline defense against neurodegenerative diseases:the development of early disease detection methods. Expert Review of Molecular Diagnostics 2019;19:559-63. [DOI: 10.1080/14737159.2019.1627202] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
70 Javed H, Azimullah S, Meeran MFN, Ansari SA, Ojha S. Neuroprotective Effects of Thymol, a Dietary Monoterpene Against Dopaminergic Neurodegeneration in Rotenone-Induced Rat Model of Parkinson's Disease. Int J Mol Sci 2019;20:E1538. [PMID: 30934738 DOI: 10.3390/ijms20071538] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
71 Ştefănescu R, Stanciu GD, Luca A, Caba IC, Tamba BI, Mihai CT. Contributions of Mass Spectrometry to the Identification of Low Molecular Weight Molecules Able to Reduce the Toxicity of Amyloid-β Peptide to Cell Cultures and Transgenic Mouse Models of Alzheimer's Disease. Molecules 2019;24:E1167. [PMID: 30909659 DOI: 10.3390/molecules24061167] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
72 Ozkizilcik A, Sharma A, Lafuente JV, Muresanu DF, Castellani RJ, Nozari A, Tian ZR, Mössler H, Sharma HS. Nanodelivery of cerebrolysin reduces pathophysiology of Parkinson's disease. Nanoneuroprotection and Nanoneurotoxicology. Elsevier; 2019. pp. 201-46. [DOI: 10.1016/bs.pbr.2019.03.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]